Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Testing effectiveness (Phase 2)Study completedNCT04815720What this trial is testingPepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Vaccinex Inc. 49
Not applicableStudy completedNCT01609023What this trial is testingRituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic LeukemiaWho this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 67
Not applicableLooking for participantsNCT04751396What this trial is testingTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsWho this might be right forAnkylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Ended earlyNCT01814046What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaWho this might be right forMetastatic Ocular MelanomaMetastatic Uveal Melanoma National Cancer Institute (NCI) 24
Not applicableUnknownNCT03253146What this trial is testingThe Role and Mechanism of Vimentin in Sepsis PatientsWho this might be right forSepsis Peking Union Medical College Hospital 200
Early research (Phase 1)Study completedNCT00274742What this trial is testingSafety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHLWho this might be right forNon-Hodgkin's Lymphoma, Relapsed Amgen Research (Munich) GmbH 76
Early research (Phase 1)Study completedNCT00864942What this trial is testingTrial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)Who this might be right forChronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma Georgetown University 28
Early research (Phase 1)Study completedNCT00614042What this trial is testingPhase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL) Aptevo Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT03097770What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20Who this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)UnknownNCT03939741What this trial is testingSVF (Adipose Tissue Derived MSC) Based Therapy for CKD.Who this might be right forChronic Kidney Diseases Bangladesh Laser & Cell Surgery Institute & Hospital 31
Not applicableStudy completedNCT02606201What this trial is testingPeri-sphincter Injection of Autologous Myofibres to Treat of Urinary Incontinence by Sphincter DeficiencyWho this might be right forUrinary Incontinence by Intrinsic Sphincter Deficiency Assistance Publique - Hôpitaux de Paris 11
Early research (Phase 1)Ended earlyNCT03486067What this trial is testingStudy of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 183
Testing effectiveness (Phase 2)Study completedNCT00308607What this trial is testingBevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaWho this might be right forMetastatic Melanoma University of Turku 27
Testing effectiveness (Phase 2)UnknownNCT02095444What this trial is testingUsing Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus InfectionWho this might be right forAcute Lung InjuryAcute Respiratory Distress Syndrome (ARDS)Multiple Organ Failure S-Evans Biosciences Co., Ltd. 20
Not applicableApproved For MarketingNCT04162756What this trial is testingStudy of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell MalignanciesWho this might be right forRelapse/Refractory Mantle Cell Lymphoma Kite, A Gilead Company
Not applicableUnknownNCT05821751What this trial is testingThe Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint InhibitorsWho this might be right forHead and Neck Squamous Cell Carcinoma Fondazione del Piemonte per l'Oncologia 40
Early research (Phase 1)Study completedNCT01300572What this trial is testingYttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDSWho this might be right forChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic Leukemia+3 more Fred Hutchinson Cancer Center 16
Early research (Phase 1)Study completedNCT01460901What this trial is testingStudy of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory NeuroblastomaWho this might be right forNeuroblastoma Children's Mercy Hospital Kansas City 5
Not applicableUnknownNCT03330353What this trial is testingChromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear PalsyWho this might be right forPSP - Progressive Supranuclear PalsyPD - Parkinson's DiseaseAD - Alzheimer's Disease+1 more Massachusetts General Hospital 56